Answers are grounded in this paper and cite their sources.
Screening tests should obey to well-defined criteria that assure that their application in asymptomatic patients results in more benefits than harms. The Erythrocyte Sedimentation Rate (ESR) is a blood test associated with severe diseases, but has low sensibility and specificity, and so it should not be used for screening purposes. In this case, the improper request of an ESR in a 48-years old man, previously healthy and asymptomatic, triggers an exhaustive cascade of tests that finally culminates in an oncologic diagnosis, but only established after the disease manifests clinically, that is, probably at the same stage as if no ESR has been dosed. On the contrary, the ESR request only resulted in the request of more tests, with more costs and potential associated risks, and in the development of an anxiety and sleep disorders that subsist even after the neoplasia remission. This case is illustrative of the iatrogenesis caused by the improper use of a test for screening purposes without any benefit in the early diagnosis and the importance of incorporating quaternary prevention in every medical intervention.
No takes yet. Share an insight, caveat, or question.
Oliveira Rm (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: